EXACT SCIENCES CORPO

EXAS
Real-time Estimate Quote. Real-time Estimate  - 05/26 02:18:02 pm
50.27USD +3.80%

Turn to zoom
Prev.48.4300
Open49.0100
High51.0100
Low47.9000
Volume1 710 715
Latest news
05/11
05/02
05/02
04/29
Chart EXACT SCIENCES CORPORATION
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBearishBearish
Resistance59,366,575,6
Spread/Res.-17%-26%-34%
Spread/Supp.3,4%3,4%17%
Support47,947,942,4
Financials
Sales 2022 2 024 M - -
Net income 2022 -760 M - -
Net Debt 2022 1 963 M - -
P/E ratio 2022 -11,3x
Yield 2022 -
Capitalization 8 521 M 8 521 M -
EV / Sales 2022 5,18x
EV / Sales 2023 4,53x
Nbr of Employees 6 460
Free-Float 99,1%
Company
Exact Sciences Corporation is a global cancer diagnostics company. The Company provides a portfolio of products for earlier cancer detection. It offers laboratory testing services from its Cologuard colorectal cancer screening test, Oncotype DX cancer diagnostic tests and services, and COVID-19...

>> Read more
Sector :
Bio Diagnostics & Testing
Calendar :
2022-06-09 Shareholder meeting
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 17
Last Close Price 48,43 $
Average target price 96,06 $
Spread / Average Target 98,4%